XeniCare II
This consultant project will provide expert advice to Roche Pharmaceuticals on the development of the Xenicare II program, a personalized support program available to consumers who use Xenical, a weight control drug.
Consulting Proposal for XeniCare II Support Program
1999-10-01 23:55
1999-12-31 23:55
Complete
Roche Pharmaceuticals Consulting
n/a
University of Michigan School of Public Health
diet, nutrition, weight loss, weight control, weight management, expert tailored
- Review a proposal by MicroMass Communications to Roche Pharmaceuticals to develop the tailored XeniCare II education and compliance program.
- Make recommendations in the areas of survey design; message composition; strength and use of tailoring including use of theory; number and timing of printed materials; and creative design.
This is not a study - there are no participants.
The HMRL's consultation will lead to recommendations in the following areas:
- Survey design
- Message composition
- Strength and use of tailoring including use of theory
- Number and timing of printed materials
- Creative design
not applicable
The HealthMedia Research Laboratory provided Roche Pharmaceuticals with a thorough review of the Xenicare II tailored intervention proposal, as designed by MicroMass Communications, Inc. Recommendations to make Xenicare II a more effective program were provided for each of the topics listed below:
- Survey design
- Message composition
- trength and use of tailoring including use of theory
- Number and timing of printed materials
- Creative design
An "evaluation and recommendation for improvements" document was provided to Roche Pharmaceuticals upon completion of review of the proposed intervention.
Users of Xenical